SARS-CoV-2 IgG and Neutralizing Antibodies Link to Neurological Symptoms; Peptide-Specific Antibodies Detected
Background
Long COVID is a complex multisystem disorder affecting millions globally, with autoimmune mechanisms strongly implicated in its pathogenesis. Current understanding of how SARS-CoV-2 infection triggers autoantibodies and immune dysregulation, contributing to persistent symptoms, remains incomplete. This study addresses this gap by elucidating the role of SARS-CoV-2-induced autoantibodies and aberrant immune activation, particularly focusing on the serological and peptide-based immune responses to viral structural proteins like Spike (S) and Nucleocapsid (N), and their potential homology to human proteins.
Study Design
Researchers analyzed serum samples from a control cohort of 315 healthcare workers, stratified by age, gender, vaccination status, and symptom clusters, for SARS-CoV-2 IgM, IgG, and Neutralizing Antibodies (NAbs) using ELISA. Bioinformatic approaches identified 29 potential epitopes within the SARS-CoV-2 Spike (S) protein and at least 1 in the Nucleocapsid (N) protein, exhibiting homology to human proteins. These epitopes were selected based on hydrophilicity, antigenicity, and homology prediction. Antibody responses to these specific peptides were then detected via ELISA in both COVID-19 infected groups (categorized as mild, moderate, or severe) and an uninfected control group.
Results
The study revealed a high seropositivity rate among the control group, with IgG detected in 97% and Neutralizing Antibodies in 94% of participants. Age-related trends showed that IgM levels increased with age, while IgG and Neutralizing Antibodies exhibited a decline. Female participants consistently demonstrated higher IgG levels compared to their male counterparts. Interestingly, antibody levels did not significantly differ across acute or persistent symptom clusters (≥ 6 months post-infection).
Key Findings
- SARS-CoV-2 IgG seropositivity was 97% and Neutralizing Antibodies 94% in the control cohort.
- Neurological symptoms (acute or chronic) were associated with elevated IgG and Neutralizing Antibody titers.
- IgM levels increased with age, while IgG and Neutralizing Antibodies declined with age.
- Female participants exhibited higher IgG levels compared to male counterparts.
- Bioinformatic analysis identified 29 potential Spike protein epitopes homologous to human proteins.
Why It Matters
This research provides critical insights into the humoral immune response to SARS-CoV-2, particularly its association with neurological symptoms, which are a hallmark of Long COVID. The identification of peptide-specific antibodies with homology to human proteins suggests a potential mechanism for autoimmunity post-infection. Understanding these specific antibody responses could lead to novel diagnostic biomarkers for Long COVID, especially for neurological manifestations, and inform the development of targeted immunomodulatory therapies. This work highlights the need for further investigation into these autoantibodies as potential therapeutic targets, moving beyond general viral antibody titers to specific epitope recognition.
sars-cov-2
covid-19
long-covid
autoimmunity
antibodies
humoral-immunity